Myovant Sciences
Brisbane, CA
Myovant Sciences Ltd. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing innovative therapies for women's health diseases and other endocrine-related disorders. Myovant Sciences develops relugolix for the treatment of heavy menstrual bleeding associated with uterine fibroids and endometriosis-associated pain.
myovant.comCompany Details
Founded
- 2016
Employees
- Between 167 - 1,000 employees
Raised
- $540,000,000
Headquarters Location
- Brisbane, CA
Public
- Yes
Acquired
- Yes
Company Collections
These are collections Myovant Sciences is a part of. Click on the collection name to view similar companies.
Myovant Sciences' Industries
Myovant Sciences' Tech Stack
Myovant Sciences Headquarters Location
Total Amount Raised: $540,000,000
Myovant Sciences Funding Rounds
Post Ipo Debt
$200,000,000
Post Ipo Debt Investors
Dainippon Sumitomo Pharma CoPost Ipo Equity
$100,000,000
Post Ipo Equity
$100,000,000
Post Ipo Equity
$100,000,000
Post Ipo Equity Investors
NovaQuest Capital ManagementPost Ipo Debt
$40,000,000
Post Ipo Debt Investors
Hercules CapitalIPO
Unknown
Myovant Sciences Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Myovant Sciences.